These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2630433)

  • 21. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata.
    Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of thyroid function and autoantibodies in patients with alopecia areata: A systematic review and meta-analysis.
    Lee S; Lee YB; Kim BJ; Lee WS
    J Am Acad Dermatol; 2019 May; 80(5):1410-1413.e4. PubMed ID: 30447313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antismooth muscle and antiparietal cell antibodies in Indians with alopecia areata.
    Kumar B; Sharma VK; Sehgal S
    Int J Dermatol; 1995 Aug; 34(8):542-5. PubMed ID: 7591433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class II alleles in patients with alopecia areata.
    Akar A; Orkunoglu E; Sengül A; Ozata M; Gür AR
    Eur J Dermatol; 2002; 12(3):236-9. PubMed ID: 11978563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hair follicle structures targeted by antibodies in patients with alopecia areata.
    Tobin DJ; Hann SK; Song MS; Bystryn JC
    Arch Dermatol; 1997 Jan; 133(1):57-61. PubMed ID: 9006373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of total immunoglobulin e in patients with alopecia areata: relationship with clinical type of the disease.
    Kasumagić-Halilović E; Prohić A
    Acta Dermatovenerol Croat; 2006; 14(3):149-52. PubMed ID: 17010262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence of thyroid disorders in patients with new onset alopecia areata.
    Lyakhovitsky A; Shemer A; Amichai B
    Australas J Dermatol; 2015 May; 56(2):103-6. PubMed ID: 25303421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T lymphocyte subpopulations in alopecia areata and psoriasis: identification with monoclonal antibodies and Fc receptors.
    Gu SQ; Petrini B; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1983; 63(3):244-6. PubMed ID: 6192643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients.
    Okamoto M; Ogawa Y; Watanabe A; Sugiura K; Shimomura Y; Aoki N; Nagasaka T; Tomita Y; Muro Y
    J Autoimmun; 2004 Nov; 23(3):257-66. PubMed ID: 15501396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients].
    Assouly P; Reygagne P; Jouanique C; Matard B; Marechal E; Reynert P; Bachelez H; Dubertret L
    Ann Dermatol Venereol; 2003 Mar; 130(3):326-30. PubMed ID: 12746668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger.
    Milgraum SS; Mitchell AJ; Bacon GE; Rasmussen JE
    J Am Acad Dermatol; 1987 Jul; 17(1):57-61. PubMed ID: 3301924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular alterations in alopecia areata.
    Recupero SM; Abdolrahimzadeh S; De Dominicis M; Mollo R; Carboni I; Rota L; Calvieri S
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():643-6. PubMed ID: 10696317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic treatment for alopecia areata.
    Otberg N
    Dermatol Ther; 2011; 24(3):320-5. PubMed ID: 21689241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial of intralesional interferon alfa in the treatment of alopecia areata.
    Magee KL; Hsu SM; Tucker SB
    Arch Dermatol; 1990 Jun; 126(6):760-2. PubMed ID: 2189361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease.
    Beccastrini E; Squatrito D; Emmi G; Fabbri P; Emmi L
    Dermatol Online J; 2010 Sep; 16(9):15. PubMed ID: 20875336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of alopecia areata in lupus erythematosus.
    Werth VP; White WL; Sanchez MR; Franks AG
    Arch Dermatol; 1992 Mar; 128(3):368-71. PubMed ID: 1550369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 308-nm excimer laser for the treatment of alopecia areata in children.
    Al-Mutairi N
    Pediatr Dermatol; 2009; 26(5):547-50. PubMed ID: 19840308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of pathologic thyroid gland findings in alopecia areata].
    Lutz G; Biersack HJ; Bauer R; Kreysel HW
    Z Hautkr; 1987 Sep; 62(17):1253-61. PubMed ID: 3687155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological profiles in alopecia areata.
    Galbraith GM; Thiers BH; Vasily DB; Fudenberg HH
    Br J Dermatol; 1984 Feb; 110(2):163-70. PubMed ID: 6607739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.
    Strober BE; Siu K; Alexis AF; Kim G; Washenik K; Sinha A; Shupack JL
    J Am Acad Dermatol; 2005 Jun; 52(6):1082-4. PubMed ID: 15928633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.